Pharma Journalist -

Minovia Therapeutics, Ltd. and Astellas Pharma Inc. announced a worldwide strategic collaboration and license agreement for the research, development, and commercialization of novel…
Read More...

SMi Reports: A free webinar led by Zeiss will take place on 7th September2021 to explore  new approaches using X ray Microscopy (XRM) from nano- to micro-scale  SMi Group is…
Read More...

Entering the fourth wave of protein engineering, increasingly more companies are engaging with ML and AI to progress R&D projects and entrants are shifting their focus to cover in…
Read More...

Takeda Pharmaceutical Company Limited and Frazier Healthcare Partners (Frazier) announced a collaboration to launch HilleVax, Inc. (HilleVax), a biopharmaceutical company to develop and…
Read More...

Shuttle Pharmaceuticals Holdings, Inc (Shuttle Pharma), a Maryland-based developer of new drugs for cancer treatment, was awarded US Patent No.: 11,034,667 B2 for "Selective Histone…
Read More...

Allergan, an AbbVie company, today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion of BOTOX to include eight new muscles for the treatment of…
Read More...

Eli Lilly and Company and Incyte announced the U.S. Food and Drug Administration (FDA) has broadened the Emergency Use Authorization (EUA) for baricitinib to allow for treatment with or…
Read More...

Melior Pharmaceuticals (Melior) announced that it completed a definitive licensing agreement with Adhera Therapeutics, Inc . for Melior’s Parkinson’s disease (PD) candidate, MLR-1019…
Read More...

The new 𝐍𝐞𝐮𝐫𝐨𝐩𝐚𝐭𝐡𝐢𝐜 𝐏𝐚𝐢𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐒𝐮𝐦𝐦𝐢𝐭 𝟐𝟎𝟐𝟏 is the only industry-dedicated event focused on discovering novel #neuropathicpain drug targets, identifying quantitative #biomarkers…
Read More...

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced four new ready-to-use AlphaLISA KRAS kits, designed to help scientists better…
Read More...